The pharmacological effects of naloxone on cerebral arterial smooth muscle in vitro were examined using canine basilar arterial strips. Naloxone exerted two different effects on canine basilar artery: (1) at a high concentration (3 x 10-4 M) it produced nonspecific va sodilation, and (2) at lower concentrations (3 x 10-7, 3 X 10-6, and 3 x 10-5 M) it inhibited the vasoconstrictor effects of norepinephrine without altering KC1-, sero tonin-, or hemoglobin-induced constriction. Morphine (2 x 10-5 or 2 x 10-4 M) did not reverse the specific va sodilating effect of naloxone (3 x 10-5 M) on norepi nephrine-induced constriction. Rather, morphine and nal oxone together produced a greater vasodilating effect on norepinephrine-induced constriction than either agent alone. Naloxone (3 x 1O-5M) failed to alter either phen-
The discovery of endogenous opiate receptors and ligands has prompted a number of investiga tions into their role in central nervous system func tion (Belenky and Holaday, 1979; Cowan et aI. , 1979; Van Vugt and Meites, 1980) . In certain cir cumstances the opiate receptor antagonist naloxone appears to have beneficial effects in the treatment of cerebral ischemia (Baskin and Hosobuchi, 1981; Iselin and Weiss, 1981; Faden et aI. , 1982; Hoso buchi et aI. , 1982) and spinal cord injury (Holaday and Faden, 1980; Faden et aI. , 1981; Young et aI. , 1981; Flamm et aI. , 1982) , but its mechanism of ac tion on cerebral circulation and metabolism is con troversial. Naloxone may alter neuronal activity through competitive inhibition of opiate receptors in the central nervous system, or it may influence the outcome through metabolic or vascular effects. ylephrine-induced constriction or clonidine-induced con striction. The vasodilating effect of naloxone (3 x 10-5 M) on 1O-3 M norepinephrine-induced constriction was not reduced with 10-6 M propranolol. These results sug gest that the vasodilating effect of naloxone on norepi nephrine-induced constriction does not result from an an tagonistic action on opiate receptors, direct inhibition of o:-adrenoreceptors, or direct stimulation of [3-adrenore ceptors in canine cerebral arterial smooth muscle. The vasodilating effect of naloxone on norepinephrine-in duced constriction may influence the CBF changes fol lowing naloxone administration. Key Words: Adrenore ceptors-Catecholamines-Cerebral arteries-Dog Naloxone.
Although many different properties of naloxone have been demonstrated Faden, 1978, 1980; Belenky and Holaday, 1979; Curtis and Lefer, 1980; Grandison et aI. , 1982; GurU et aI., 1982) , there has been no detailed investigation of its phar macological effect on cerebral arterial smooth muscle. In a previous study, we detected two dif ferent effects of naloxone on canine mesenteric ar tery in vitro: (1) at a high concentration (3 x 10-4 M), it produced nonspecific vasodilation, and (2) at lower concentrations (3 x 10 -7 to 3 X 10-5 M) it augmented the vasoconstrictor effects of epineph rine without altering KCI-or serotonin-induced con striction (Sasaki et aI. , unpublished data). There fore, it seems reasonable to assume that naloxone possesses some pharmacological property that al ters contractile activity of cerebral arterial smooth muscle. If so, such information might be helpful in elucidating the mechanism of the beneficial effects of naloxone in the treatment of cerebral ischemia and spinal cord injury. The study described here was undertaken to investigate the pharmacological effects of naloxone on cerebral arterial smooth muscle in vitro.
MATERIALS AND METHODS
Adult mongrel dogs of either sex, weighing 12-18 kg, were anesthetized with sodium pentobarbital (30 mg/kg) and sacrificed by exsanguination from the femoral artery. The brain was then rapidly removed. The basilar artery was dissected from the brain under magnification and im mediately placed in modified Kreb's bicarbonate solution (NaCl 120 mM, KCI 4.5 mM, MgS04 1.0 mM, NaHC0 3 27.0 mM, KH2P04 1.0 mM, CaCI2 2.5 mM, dextrose 10.0 mM] at 37°C, which was gassed with 95% O2 and 5% CO2,
The pH of the solution ranged from 7.40 to 7.50. The arteries were cut into 4-mm-Iong ring segments and sus pended between L-shaped stainless steel holders in organ baths with a IO-ml working volume. The resting tension was adjusted to 2 g, and the preparations were allowed to equilibrate at 37°C for 90 min before use.
Dose-response curves for KCI, serotonin, hemoglobin, epinephrine, norepinephrine, phenylephrine, and c1oni dine were obtained by cumulative addition of the ago nists.
The contractile force was recorded isometrically using a Grass FT.03 force-displacement transducer. The trans ducer signal was amplified and displayed on a Gould 260 multichannel recorder. The contractile force induced by KCI was expressed in grams, and the contractile activity induced by other agonists as a percentage of the contrac tion elicited by a standard dose of 40 mM KCI.
Pure naloxone was used in this experiment. In studies examining the effects of naloxone on vascular smooth muscle, preparations were exposed to naloxone (3 x 10-7, 3 X 10-6, 3 x 10-5, and 3 x 10-4 M) for 2 min before the addition of agonists.
In the experiment designed to test the influence of 13adrenoreceptors on the ability of naloxone to suppress norepinephrine-induced constriction, preparations were exposed for 10 min to propranolol (10-6 M) before the addition of naloxone (3 x 10-5 M).
Hemoglobin was prepared as follows: Blood was ob tained from dogs by arterial puncture and added to tubes containing citrate (4 ml of 3.2% sodium citrate per 20 ml of blood). The tubes were centrifuged at 1,500 g for 10 min at 4°C, after which the plasma was discarded. The blood cells were then washed five times with 3 volumes of ice-cold 0.9% sodium chloride, and the buffy coat re moved. An equal volume of distilled water was added to the packed cells, and the mixture was agitated for 5 min. The lysed red cells were then centrifuged at 15,000 g for 20 min to remove the stroma. To remove low molecular weight substances, the destromatized hemolysate was ap plied to a Sephadex G-50-80 column (2.7 x 45 cm) which was equilibrated with 0.05 M Tris-HCI buffer (pH 7.4). The concentration of hemoglobin was estimated from the absorbance of the solutions at 540 nm using a molar ex tinction coefficient of 13.8 x 103.
Statistical analysis of the dose-response curves was made using split-plot analysis of variance (ANOVA), and a Scheffe test was used for subgroup analysis. A com parison of each constrictor response with a matched con trol at a specific naloxone concentration and at each spe cific agonist concentration was made using a paired t test. For graphic presentation the control values were aver-aged together. The values were considered to be signifi cantly different if p was <0.05.
The drugs and solutions used in this study were 5-hy droxytryptamine (Sigma Chemical Co.), (± )-arterenol hydrochloride (Sigma), (-)-epinephrine (+ )-bitartrate (Sigma), I-phenylephrine hydrochloride (Sigma), c1oni dine hydrochloride (Boehringer Ingelheim Ltd.), dl-pro pranolol hydrochloride (Sigma), d-Ala-methionine en kephalinamide (Sigma), morphine sulfate (Elkins-Sinn, Inc.), and naloxone (Endo Laboratories, Inc., lot 82-037). Norepinephrine, epinephrine, or hemoglobin was dis solved using a 50 mM phosphate buffer solution (pH 7.4). Other drugs were dissolved using saline solution.
RESULTS
Naloxone at a concentration of 3 x 10 -7, 3 X 10 -6, or 3 x 10-5 M showed no effect on the con tractile activity of canine basilar arteries under resting tension, while 3 x 10-4 M naloxone pro duced relaxation of the arteries (31.3% ± 4.3, n = 10).
Effects of naloxone on KCI-, serotonin-, and hemoglobin-induced contraction
Naloxone at 3 x 10-4 M suppressed the con traction induced by KCI at all concentrations tested (20, 40, 60, and 80 mM) (Scheffe test, p < 0.001), though at lower concentrations (3 x 10 -7, 3 X 10-6, and 3 x 10 -5 M) it failed to alter the con tractile activity produced by KCI ( Fig. 1) . No effect was observed on the contraction induced by he moglobin using 3 x 10-7, 3 X 10-6, or 3 x 10-5 M naloxone, while 3 x 10-4 naloxone suppressed hemoglobin-induced contraction at all concentra tions tested (l0 -8, 10-7, 10-6, and 10-5 M) (Scheffe test, p < 0.001) ( Fig. 2) . With respect to the effect of naloxone on serotonin-induced contraction, 3 x 10-7, 3 X 10-6 M, and 3 x 10-5 M naloxone did not show any effect. At the highest dose tested (3 x 10-4 M), naloxone suppressed the serotonin dose-response curve (Scheffe test, p < 0.001) ( Fig.  3) .
Effects of naloxone on norepinephrine-and epinephrine-induced contraction
At all concentrations tested naloxone showed an inhibitory effect on norepinephrine dose-response curves for basilar arteries (AN OVA and Scheffe test, p < 0.005) . We analyzed the results for matched control and naloxone-treated vessels by a paired t test, and naloxone concentrations of 3 x 10-7 and 3 x 10-6 M suppressed the contraction induced by 10-5, 10-4, 10-3, and 3 x 10-3 M nor epinephrine. The results were inconsistent for the effect of 3 x 10-5 M naloxone with low concentra tions of norepinephrine, while 3 x 10-5 M naloxone showed an inhibitory effect on the contraction in- duced by 10-3 and 3 x 10-3 M norepinephrine. Naloxone at 3 x 10-4 M inhibited the contraction induced by 10-5, 10-4, 10-3, and 3 x 10-3 M nor epinephrine. This effect of naloxone at different concentrations (3 x 10-7 to 3 X 10-4 M) on nor epinephrine-induced contraction was more marked at higher concentrations (10 -3 and 3 x 10 -3 M) of norepinephrine ( Fig. 4) .
Compared to norepinephrine-induced contrac tion, epinephrine-induced contraction was not strong enough to evaluate the effect of naloxone. In two dogs, however, in which epinephrine did pro duce moderate constriction, naloxone at all concen trations tested (3 x 10-7 to 3 X 10-4 M) showed inhibitory effects similar to those observed after norepinephrine-induced constriction (Fig. 5) .
Effects of naloxone on other a-adrenoreceptor agonists
The effects of naloxone on contraction induced by the ucadrenoreceptor agonist phenylephrine and the u2-adrenoreceptor agonist clonidine are shown in Fig. 6 . Naloxone concentrations of 3 x 10-6 and 3 x 10-5 M failed to alter the contractile activity of basilar artery induced by either phenylephrine or clonidine. The contractile activity induced by 10-3 M nor epinephrine was slightly augmented (9.5% ± 2. 7, mean ± SEM) by treating preparations with 10-6 M propranolol. Naloxone (3 x 10-5 M) suppressed norepinephrine-induced constriction in the absence and in the presence of 10-6 M propranolol. There was no statistically significant difference in the amount of inhibition induced by naloxone in the groups treated or not treated with propranolol ( Fig. 7) .
Influence of opiate agonists
D-Ala-Met-Enkephalin at concentrations of 10-7, 10-6, and 10-5 M exhibited no effect on basilar ar tery under resting tension (n = 4). The effects of morphine on the arteries under resting tension were variable. In five of nine dogs, morphine (2 x 10-7 to 2 X 10-4 M) relaxed the arteries, while in an other four, morphine (2 x 10-6 to 2 X 10-4 M) produced weak, phasic constriction which was not inhibited by naloxone (3 x 10-5 M). The adminis tration of morphine (2 x 10 -5 or 2 x 10 -4 M) either before or after 10-3 M norepinephrine-induced con striction suppressed the constriction. In addition, morphine (2 x 10-5 or 2 x 10-4 M) and naloxone (3 x 10-5 M) produced mutually augmenting va sodilating effects on 10 -3 M norepinephrine-in duced constriction (Fig. 8) .
DISCUSSION
Although many different properties of naloxone have been demonstrated Faden, 1978, 1980; Belenky and Holaday, 1979; Curtis and Lefer, 1980; Baskin and Hosobuchi, 1981; Iselin and Weiss, 1981; Young et aI. , 1981) , little has been re ported on the pharmacological effects of naloxone on vascular smooth muscle. In a previous study (Sasaki et aI. , unpublished data), we evaluated the effects of naloxone on the contraction of canine mesenteric artery in vitro and detected two different effects: (1) naloxone at a high concentration (3 x 10-4 M) produced nonspecific vasodilation, and (2) naloxone at lower concentrations (3 x 10 -7, 3 X 10-6, and 3 x 10-5 M) augmented the vasocon- (10-4,10-3, and 3 x 10-3 M). These results suggest that high concentrations of naloxone exert a non specific and possibly local anesthetic-like vasodi lating effect on canine cerebral artery. The vasodi lating effect cannot be attributed to the preserv atives in the Nalonee® preparation of naloxone, since pure naloxone was used in our experiment, though Brandt et al. (1983) have reported that pre servatives have relaxant effects on the vascular smooth muscle. Such a nonspecific vasodilating ef fect of naloxone at a high concentration was also observed in canine mesenteric artery (Sasaki et al. , unpublished data) . These results appear to be con sistent with the report by Lee and Berkowitz (1976) that naloxone at high concentrations (3 x 10-4 to 1 X 10-3 M) reduced rat aortic contraction pro duced by I-pentazosine, KCI, and norepinephrine. The results of this experiment also demonstrated that naloxone at lower concentrations (3 x 10-7 to 3 x 10 -5 M) inhibited norepinephrine-and epi nephrine-induced contraction of canine basilar ar tery, though it failed to alter the vasocontractile ac tivity induced by KCI, hemoglobin, or serotonin. This inhibitory effect of naloxone was evident par ticularly when constriction was induced by norepi nephrine or epinephrine at high concentrations.
In an attempt to investigate the mechanism of the inhibitory effects of naloxone on epinephrine-and norepinephrine-induced contraction, the effects of naloxone on the contraction induced by other u adrenoreceptor agonists were examined. Naloxone (3 x 10-6 and 3 x 10-5 M) failed to alter the va socontractile activity of canine basilar artery in duced by either the u1-adrenoreceptor agonist phen ylephrine or the u2-adrenoreceptor agonist cloni dine. The mechanism of the clonidine-induced , constriction of cerebral artery has not yet been clar ified. The presence of a2-adrenoreceptors in cere bral arterial smooth muscle, though previously found in the central nervous system (Young and Kuhar, 1979) , is still controversial (Bevan, 1980; Skarby et al. , 1981; Sakakibara et aI. , 1982; Medgett and Langer, 1983) . In another experiment (Sasaki et aI. , unpublished data), clonidine-induced con traction was not inhibited by the a2-adrenoreceptor antagonist yohimbine. Therefore, clonidine-in duced contraction of canine basilar artery may not be mediated through az-adrenoreceptors but through another mechanism. Parenthetically, the in hibitory effects of naloxone on epinephrine-and norepinephrine-induced constriction of canine bas ilar artery do not appear to be explained by direct inhibition of a-adrenoreceptors in cerebral arterial smooth muscle.
The possibility that naloxone may exert its va sodilating effect on norepinephrine-induced con striction by stimulating l3-adrenoreceptors was also examined. The vasodilating effect of naloxone on norepinephrine-induced constriction was not re duced by treating preparations with propranolol. Therefore, it seems unlikely that naloxone sup presses norepinephrine-induced constriction by acting as a l3-adrenoreceptor agonist.
Concerning the opiate antagonistic effects of nal oxone on vascular smooth muslce contractions, it has been reported that morphine and enkephalin di late the tonic contraction of cat cerebral artery in duced by prostaglandin F2a and that naloxone re verses the opioid-induced vasodilatation (Hanko et aI. , 1981) . The results of this experiment, however, revealed that naloxone (3 x 10-5 M) did not reverse but rather augmented the vasodilating effects of morphine on 10-3 M norepinephrine-induced con- , I , traction of canine basilar artery. In light of these results, it appears that the inhibitory effect of nal oxone on epinephrine-and norepinephrine-induced contraction of canine basilar artery does not result from an antagonistic action on opiate receptors. Further studies will be necessary to investigate the precise mechanism of this vasodilating effect of nal oxone.
The effects of naloxone at lower concentrations (3 x 10-7, 3 X 10-6, and 3 x 10-5 M) on epi nephrine and norepinephrine-induced contraction are quite different when comparing canine basilar artery to mesenteric artery. In canine basilar artery, naloxone (3 X 10-7 to 3 X 10-5 M) selectively inhibited epinephrine-and norepinephrine-induced contraction. However, naloxone (3 x 10 -7 to 3 x 10 -5 M) selectively augmented epinephrine-and norepinephrine-induced contraction of mesenteric artery (Sasaki et aI. , unpublished data). The mech anism of this difference in naloxone action on epi nephrine-and norepinephrine-induced contraction of cerebral versus splanchnic artery is still un known.
The vasodilating effect of naloxone on norepi nephrine-induced constriction of cerebral arteries may influence the CBF changes following naloxone administration. This hypothesis seems to be sup ported by the observation that naloxone induces in creases in CBF more pronounced in dogs made acutely hypertensive by intravenous norepineph rine infusion than in normotensive dogs (Turner et aI. , 1984) .
Although naloxone has been shown in this study to exert vasodilating effects on epinephrine-and norepinephrine-induced constriction of canine ce rebral artery, there may be species differences in the vasoconstrictor response of cerebral arterial smooth muscle to naloxone, since varying effects of naloxone on CBF in different species have been demonstrated. For instance, naloxone increases CBF in dogs (Faden et aI. , 1982; Tu rner et aI. , 1984) , decreases CBF in cats (Grandison et aI. , 1982) , and fails to alter CBF in monkeys (Nehls et aI. , 1983) and humans (Sugar, 1982) . Such species differences in CBF responses to naloxone merit further evalu ation of the direct pharmacological effects of this agent on cerebral smooth muscle in different spe cies. Brandt et ai. (1983) recently reported that pure naloxone had no effect on potassium-or prosta glandin Fzu-induced contractions of human pial ar teries. However, the effect of pure naloxone on epi nephrine-or norepinephrine-induced contraction was not evaluated.
